AMPHASTAR PHARMACEUTICALS, INC.

Amphastar Pharmaceuticals, Inc. specializes in the manufacturing of sterile pharmaceutical preparations, with a focused expertise in the production of active pharmaceutical ingredients and finished dosage forms used in clinical settings. Their technical capabilities include aseptic processing, formulation development, and quality control systems compliant with cGMP standards, ensuring the consistent production of injectable and hematology-related therapeutics. The company’s operations emphasize regulatory adherence, batch traceability, and process validation critical to federal supply chains, particularly for high-acuity medications requiring strict sterility and potency controls. Their specialization in complex drug products positions them as a reliable source for mission-critical pharmaceuticals used in institutional and veteran healthcare environments. Amphastar has delivered pharmaceutical products to the Department of Veterans Affairs under a Federal Supply Schedule contract, indicating a proven ability to meet the VA’s stringent requirements for drug availability, shelf-life management, and distribution logistics in VA medical centers. Their engagement reflects a track record of supporting veteran-specific therapeutic needs, including hematologic and chronic condition treatments, through reliable, scalable manufacturing capacity aligned with federal procurement protocols. The contractor’s primary industry focus is pharmaceutical preparation manufacturing (NAICS 325412), which encompasses the synthesis, blending, and packaging of injectable and other sterile drug products for institutional use. They serve the niche market for specialized pharmaceuticals requiring controlled environments and regulatory rigor, distinguishing themselves through precision manufacturing rather than broad product portfolios. Amphastar Pharmaceuticals, Inc. is a privately held, for-profit entity headquartered in Rancho Cucamonga, California. While no federal certifications are currently listed, their operations are structured to comply with FDA and DEA regulations governing controlled substance manufacturing. Their geographic presence supports federal supply chain demands on the West Coast, with capabilities calibrated to serve government health systems requiring consistent, high-integrity pharmaceutical sourcing.